News Research Still Time To Participate In UK Medical Cannabis Trial

Still Time To Participate In UK Medical Cannabis Trial

-

Advertising

EUROPE’S largest ever medical cannabis trial is still recruiting patients as it looks to gather further evidence to support its wider adoption.

Known as Project 21, the two-year trial was launched by Britain’s former Drugs Czar Prof David Nutt. He is seeking to recruit 20,000 patients.

Project 21’s partners include the United Patients Alliance and The Royal College of Psychiatrists (RCP), with the aim of creating the largest European medical cannabis body of evidence.

It is being backed by three medical cannabis businesses – Italian company Althea and UK, Firms Alta-Flora and Canuba – who will supply subsidised cannabis medicine.

The trial will focus on a number of conditions including; chronic pain, epilepsy, multiple sclerosis, post-traumatic stress disorder, Tourette’s syndrome, anxiety disorder or who have had a history of substance misuse.

Patients Are Forced to Break Law

Prof Nutt stated that up until 1971 cannabis had been used as a medicine in the UK for over a century before ‘it was banned for political reasons’

“Since then hundreds of thousands of patients have been forced to break the law to get a treatment that most find preferable to their previous prescription medicines,” he said.

He said Project 21 will provide a ‘solid clinical database from which experience of and confidence in, medical cannabis prescribing will develop, providing a foundation for other medical prescribers to build on’.

Professor Wendy Burn, the RCP president  said it hopes the trial will ‘address the paucity of evidence’ for the use of cannabis-based medicine.

Dr Arun Bhaskar, President of the British Pain Society said some 28m people in the UK will at some stage, suffer from chronic pain.

“Data from several countries reveal that medical cannabis have benefited several thousands of patients,”he added.

Prof Nutt, dismissed by the UK Government for saying alcohol and tobacco are more dangerous to health than ecstasy, LSD and cannabis, went on to form Drugs Science – an independent, science-led drugs charity.

For information on how to participate in the trial visit: https://drugscience.org.uk/project-twenty21/

Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

When Is The Best Time – And With Whom – To Launch The Required Toxicology Tests For A UK CBD Novel Food Pass?

FOOD regulators have unveiled further key details for CBD businesses looking to operate in the UK post-Brexit.

Europe’s CBD U-Turn Set To Cause Widespread Harm To Businesses And Consumers

CONFIRMATION that the European Union is looking to treat CBD as a narcotic drug have rocked the...

Europe’s CBD Brexit; On The Continent It’s Now A ‘Drug’ – In The UK It’s A Food

THE next few months look like being crucial for the CBD industry following confirmation the European Union...

£28m UK Horticultural Firm Turns To Cannabis: ‘We are learning More And More About This Fascinating Plant’

WITH the equivalent of over 35 football pitches of covered growing space and the potential to add...

Advertising

New MD To Usher In Era Of Change At Europe’s Largest Cannabis Trade Group

THE new Managing Director of the Cannabis Trades Association says it’s time for a re-set as she...

Can New Irish Government Deliver On Medicinal Cannabis? One-Year-Old Scheme Currently Has No Patients

IN June last year the Irish Government signed-off on its five-year medicinal cannabis programme - but no...

Must read

Advertising

You might also likeRELATED
Recommended to you